珠江啤酒(002461.SZ)2020年半年度淨利潤預增10%-30%
格隆匯 7 月 13日丨珠江啤酒(002461.SZ)公佈,預計2020年半年度歸屬於上市公司股東的淨利潤2.33億元-2.75億元,同比增長10%-30%。
報告期,公司發動全體員工積極克服疫情影響,齊心協力完成各項工作任務。在營銷方面,公司採取多種措施激活了疫情防控下被壓抑的啤酒需求、提振了市場對珠江啤酒的消費熱情,公司第二季度啤酒銷量恢復同比增長;持續優化以“三線”產品為主、特色差異化產品為輔的產品結構,拓寬了利潤增長點。在生產及管理等方面,堅持管理出效益,凝聚智慧開展“開源節流、降本增效”專項行動,嚴控各項消耗和費用支出,推進降本增效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.